(HealthDay News) — American seniors still pay more for health care than their counterparts in most other wealthy countries do, despite coverage by Medicare, a new study finds. They are also more ...
Prices of cancer drugs increase “substantially” after they are launched in the United States, according to researchers.
Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...
(HealthDay News) — President-elect Donald Trump has tapped Dr. Jay Bhattacharya, a Stanford health economist and critic of pandemic lockdowns and vaccine mandates, to lead the nation’s largest medical ...
Authors say findings may be due to relative excess of thyroid hormone even when treatment is targeted to reference range goals ...
The First To Know Syphilis Test is now available for purchase nationwide to be used for at-home testing of suspected syphilis ...
(HealthDay News) — Younger age at diagnosis of type 2 diabetes is significantly associated with a higher risk for subsequent dementia, according to a study published online in PLOS ONE.
Prescription rates increased from 2021 to 2023, but high variance seen between hospitals in the rate of prescriptions ...
Pre-operative fractionated stereotactic radiotherapy (FSRT) “compares favorably” to post-operative FSRT, according to researchers.
These 8 factors reversely associated with the age-standardized incidence rates of ischemic heart disease, stroke ...
Risk for all-cause mortality and MACEs are affected by calcified and low-attenuation plaque burdens in patients with chronic kidney disease.
Tolvaptan efficacy was assessed among younger adults 18-35 years with autosomal dominant polycystic kidney disease (ADPKD), who are at high risk for progression.